Investigation on the Management for Patients with Echinococcosis Treated with Albendazole — Three PLADs, China, 2019

WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? In China, patients with echinococcosis receive complimentary healthcare services, such as medical treatment, diagnostic examinations, and follow-up care. Despite this, no studies have been conducted to assess the quality of patient management to date. WHAT IS...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Min, Wang, Liying, Wang, Ying, Wang, Xu, Lei, Jiaxi, Cheng, Xixi, Feng, Yu, Hou, Yanyan, Wang, Qian, Xue, Chuizhao, Gavotte, Laurent, Frutos, Roger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2023
Materias:
Preplanned Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236642/
https://www.ncbi.nlm.nih.gov/pubmed/37274767
http://dx.doi.org/10.46234/ccdcw2023.083
Descripción
Sumario:WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? In China, patients with echinococcosis receive complimentary healthcare services, such as medical treatment, diagnostic examinations, and follow-up care. Despite this, no studies have been conducted to assess the quality of patient management to date. WHAT IS ADDED BY THIS REPORT? This study reviewed the medical records of 899 patients who underwent albendazole treatment across 10 endemic counties. Out of 634 evaluable patient files, the proportion of patients with a ratio of actual follow-up and reexamination times to theoretical follow-up and reexamination times ≥0.8 were both low (21.92% and 23.19%, respectively). WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICES? This study identified weaknesses and specific issues in patient management and proposed feasible recommendations to enhance patient file documentation, follow-up, and reexamination.

Ejemplares similares